Winst gevend schreef op 29 augustus 2019 16:45:
Niet TE VROEG juichen - Pharming CIN
A secondary endpoint measured was Troponin T, a marker of cardiovascular damage caused by the
examination or intervention itself,
but this did not show a meaningful difference in the overall study
population: the power of the study and the variety of interventions applied were
not suitable to
perform an appropriate evaluation.Grote pipeline, maar nog geen millimeter opgeschoten.